Dr. Reddy's Laboratories Limited
RDY
$12.08
-$0.15-1.19%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 101.72% | -82.87% | -17.48% | -0.65% | -10.02% |
| Total Depreciation and Amortization | -3.55% | 0.75% | 1.15% | 3.90% | 5.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 100.37% | -65.46% | 230.44% | -132.69% | 326.24% |
| Change in Net Operating Assets | -265.95% | 183.89% | -211.57% | 69.41% | -1,518.66% |
| Cash from Operations | -105.93% | 35.10% | -31.35% | 4.35% | -32.73% |
| Capital Expenditure | 24.42% | 36.24% | -25.79% | 25.38% | 9.43% |
| Sale of Property, Plant, and Equipment | 127.01% | 1,378.18% | -91.09% | 236.99% | 423.72% |
| Cash Acquisitions | 93.01% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 137.61% | -396.17% | 20.40% | 64.88% | -214.74% |
| Cash from Investing | 114.50% | -142.40% | -5.70% | 51.26% | -45.96% |
| Total Debt Issued | -- | -4.01% | 244.38% | 3,621.43% | 101.43% |
| Total Debt Repaid | -1,316.30% | -42.71% | -20.50% | 26.69% | -28.85% |
| Issuance of Common Stock | 213.92% | 163.33% | -67.39% | -53.06% | 1,681.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | 100.00% | -- | -- |
| Other Financing Activities | -24.52% | -32.48% | 16.58% | 1.84% | -35.11% |
| Cash from Financing | -201.22% | -14.75% | 243.18% | -333.72% | 83.49% |
| Foreign Exchange rate Adjustments | -92.39% | 34.97% | 79.92% | 7.99% | -23.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.89% | -135.40% | 850.80% | 115.82% | -462.15% |